Table 4.
Small ncRNA pair panels | Sample size | SEN | SPE | PPV | NPV | FPR | FNR | AUC |
---|---|---|---|---|---|---|---|---|
Panel 1: LAC+Benign vs. Control | ||||||||
Training | 85 vs. 29 | 1.000 | 1.000 | 1.000 | 1.000 | 0.000 | 0.000 | 1.000 |
Validation | 76 vs. 51 | 0.915 | 0.804 | 0.855 | 0.882 | 0.196 | 0.085 | 0.902 |
Panel 1: LAC vs. Control | ||||||||
Training | 50 vs. 29 | 1.000 | 1.000 | 1.000 | 1.000 | 0.000 | 0.000 | 1.000 |
Validation | 44 vs. 51 | 0.854 | 0.833 | 0.795 | 0.882 | 0.167 | 0.146 | 0.895 |
Panel 2: LAC vs. Benign | ||||||||
Training | 50 vs. 35 | 0.811 | 0.781 | 0.860 | 0.714 | 0.219 | 0.189 | 0.820 |
Validation | 44 vs. 32 | 0.704 | 0.727 | 0.864 | 0.500 | 0.273 | 0.296 | 0.742 |
AUC area under receiver operating characteristic curve, FNR false negative rate, FPR false positive rate, LAC lung adenocarcinoma, NPV negative predictive value, PPV positive predictive value, SEN sensitivity, SPE specificity